Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.73M Sell
25,931
-1,062
-4% -$125K 0.06% 291
2025
Q4
$3.37M Buy
26,993
+19,711
+271% +$2.35M 0.07% 246
2025
Q3
$873K Sell
7,282
-512
-7% -$54.1K 0.03% 407
2025
Q2
$715K Buy
7,794
+4,720
+154% +$431K 0.02% 476
2025
Q1
$270K Buy
3,074
+129
+4% +$12.7K 0.02% 448
2024
Q4
$272K Buy
+2,945
New +$283K 0.02% 504

Other funds holding CRH

Callan Family Office's CRH Position: Q1 2026 in Review

Callan Family Office reduced its CRH (CRH) stake by 3.9% in Q1 2026, selling an estimated $125K and leaving 25,931 shares worth $2.73M. The position accounts for 0.06% of the portfolio, ranked #291.

Callan Family Office first reported a position in CRH in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.37M in Q4 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Callan Family Office held 25,931 shares of CRH worth $2.73M as of Q1 2026.
  • Callan Family Office sold 1,062 CRH shares in Q1 2026, an estimated $125K.
  • CRH made up 0.06% of Callan Family Office's portfolio in Q1 2026, its #291 holding.
  • Callan Family Office first reported a position in CRH in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's CRH position peaked at $3.37M in Q4 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.